Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
James Jerome Marnock, M.D.
Family Practice · BLACK MOUNTAIN, NC · NPI 1194899617
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Rosuvastatin Calcium | Rosuvastatin Calcium | 666 | 203 |
| Atorvastatin Calcium | Atorvastatin Calcium | 512 | 151 |
| Levothyroxine Sodium | Levothyroxine Sodium | 492 | 133 |
| Amlodipine Besylate | Amlodipine Besylate | 425 | 123 |
| Losartan Potassium | Losartan Potassium | 386 | 112 |
| Lisinopril | Lisinopril | 366 | 111 |
| Eliquis | Apixaban | 260 | 46 |
| Omeprazole | Omeprazole | 260 | 85 |
| Metoprolol Succinate | Metoprolol Succinate | 259 | 78 |
| Pantoprazole Sodium | Pantoprazole Sodium | 251 | 80 |
| Hydrochlorothiazide | Hydrochlorothiazide | 230 | 75 |
| Gabapentin | Gabapentin | 223 | 55 |
| Famotidine | Famotidine | 201 | 68 |
| Escitalopram Oxalate | Escitalopram Oxalate | 176 | 57 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 168 | 64 |
| Meloxicam | Meloxicam | 162 | 57 |
| Tamsulosin Hcl | Tamsulosin Hcl | 146 | 50 |
| Allopurinol | Allopurinol | 124 | 34 |
| Celecoxib | Celecoxib | 113 | 32 |
| Trazodone Hcl | Trazodone Hcl | 113 | 38 |
| Ozempic | Semaglutide | 97 | 11 |
| Sertraline Hcl | Sertraline Hcl | 97 | 36 |
| Jardiance | Empagliflozin | 96 | 25 |
| Spironolactone | Spironolactone | 95 | 26 |
| Montelukast Sodium | Montelukast Sodium | 91 | 25 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 88 | 27 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 88 | 22 |
| Glipizide Er | Glipizide | 86 | 21 |
| Fluticasone Propionate | Fluticasone Propionate | 84 | 38 |
| Pravastatin Sodium | Pravastatin Sodium | 83 | 26 |
| Ibandronate Sodium | Ibandronate Sodium | 80 | 27 |
| Clopidogrel | Clopidogrel Bisulfate | 78 | 18 |
| Finasteride | Finasteride | 75 | 25 |
| Furosemide | Furosemide | 74 | 31 |
| Metoprolol Tartrate | Metoprolol Tartrate | 73 | 21 |
| Atenolol | Atenolol | 71 | 21 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 71 | 19 |
| Valsartan | Valsartan | 71 | 15 |
| Xarelto | Rivaroxaban | 69 | 15 |
| Bupropion Xl | Bupropion Hcl | 68 | 21 |
| Duloxetine Hcl | Duloxetine Hcl | 66 | 19 |
| Metformin Hcl | Metformin Hcl | 65 | 17 |
| Tizanidine Hcl | Tizanidine Hcl | 65 | 17 |
| Zolpidem Tartrate | Zolpidem Tartrate | 65 | 14 |
| Prednisone | Prednisone | 62 | 55 |
| Metformin Hcl Er | Metformin Hcl | 61 | 21 |
| Potassium Chloride | Potassium Chloride | 61 | 17 |
| Carvedilol | Carvedilol | 52 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 52 | 18 |
| Buspirone Hcl | Buspirone Hcl | 50 | 19 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 50 | suppressed |
| Lorazepam | Lorazepam | 47 | suppressed |
| Simvastatin | Simvastatin | 45 | 13 |
| Azithromycin | Azithromycin | 44 | 42 |
| Tramadol Hcl | Tramadol Hcl | 44 | 11 |
| Fluoxetine Hcl | Fluoxetine Hcl | 43 | 12 |
| Alendronate Sodium | Alendronate Sodium | 42 | 12 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 40 | 13 |
| Mirtazapine | Mirtazapine | 39 | suppressed |
| Glimepiride | Glimepiride | 38 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 35 | 32 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 35 | 15 |
| Amitriptyline Hcl | Amitriptyline Hcl | 34 | suppressed |
| Amlodipine-Valsartan | Amlodipine Besylate/Valsartan | 33 | suppressed |
| Synthroid | Levothyroxine Sodium | 30 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 30 | 12 |
| Ventolin Hfa | Albuterol Sulfate | 30 | 13 |
| Telmisartan | Telmisartan | 29 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 29 | 13 |
| Doxazosin Mesylate | Doxazosin Mesylate | 28 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 28 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 28 | suppressed |
| Bumetanide | Bumetanide | 27 | suppressed |
| Irbesartan | Irbesartan | 27 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 27 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 26 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 26 | suppressed |
| Ezetimibe | Ezetimibe | 26 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 26 | 26 |
| Symbicort | Budesonide/Formoterol Fumarate | 26 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 25 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 25 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 25 | 22 |
| Pregabalin | Pregabalin | 25 | suppressed |
| Alprazolam | Alprazolam | 24 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 24 | suppressed |
| Lamotrigine | Lamotrigine | 24 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 24 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 24 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 24 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 24 | 22 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 24 | 21 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 23 | suppressed |
| Myrbetriq | Mirabegron | 23 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 23 | 12 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 22 | suppressed |
| Baclofen | Baclofen | 21 | 12 |
| Fluconazole | Fluconazole | 21 | 17 |
| Meclizine Hcl | Meclizine Hcl | 21 | suppressed |
| Memantine Hcl | Memantine Hcl | 21 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 21 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 21 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 21 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 20 | 19 |
| Chlorthalidone | Chlorthalidone | 18 | suppressed |
| Colchicine | Colchicine | 18 | 13 |
| Diclofenac Sodium | Diclofenac Sodium | 18 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 18 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 18 | suppressed |
| Nifedipine Er | Nifedipine | 18 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 18 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 17 | suppressed |
| Ketoconazole | Ketoconazole | 17 | 14 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 17 | suppressed |
| Amoxicillin | Amoxicillin | 16 | 15 |
| Ibuprofen | Ibuprofen | 16 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 16 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 15 | suppressed |
| Epinephrine | Epinephrine | 15 | 13 |
| Lovastatin | Lovastatin | 15 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 15 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 14 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 14 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 13 | suppressed |
| Fenofibrate | Fenofibrate | 13 | suppressed |
| Ondansetron Odt | Ondansetron | 13 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 13 | suppressed |
| Topiramate | Topiramate | 13 | suppressed |
| Carbamazepine Er | Carbamazepine | 12 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 12 | suppressed |
| Famciclovir | Famciclovir | 12 | suppressed |
| Trulicity | Dulaglutide | 12 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 11 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 11 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 11 | suppressed |
| Methocarbamol | Methocarbamol | 11 | suppressed |
| Nystatin | Nystatin | 11 | suppressed |
| Torsemide | Torsemide | 11 | suppressed |
| Vyvanse | Lisdexamfetamine Dimesylate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error